FOCUS ENT & Allergy Insights

Benefits of Hiring an Investment Banker

Benefits of Hiring an Investment Banker

By Eric Yetter|February 12, 2026|Articles, Behavioral Health, Biotech, Blogs, Cardiology, Dermatology, ENT & Allergy, Gastroenterology, Healthcare, Home Health & Hospice, Life Sciences, Ophthalmology, Orthopedics, Urology, Women's Health|

Expert Analysis Benefits of Hiring an Investment Banker Selling a ...

Infusion Therapy Services Market Update: Q1 2025

Infusion Therapy Services Market Update: Q1 2025

By Eric Yetter|April 9, 2025|Articles, Behavioral Health, Biotech, Blogs, Cardiology, Dermatology, ENT & Allergy, Gastroenterology, Healthcare, Home Health & Hospice, Life Sciences, Ophthalmology, Orthopedics, Urology, Women's Health|

Infusion Therapy Services Market Update Investments in the ...

More Varied Deal Structures Among Healthcare Providers are Another Reason Sellers Need Competitive Auctions

More Varied Deal Structures Among Healthcare Providers are Another Reason Sellers Need Competitive Auctions

By Eric Yetter|March 7, 2025|Articles, Behavioral Health, Biotech, Blogs, Cardiology, Dermatology, ENT & Allergy, Gastroenterology, Healthcare, Home Health & Hospice, Life Sciences, Ophthalmology, Orthopedics, Urology, Women's Health|

More Varied Deal Structures Among Healthcare Providers are Another ...

Mid-Michigan ENT Case Study

Mid-Michigan ENT Case Study

By Eric Yetter|September 30, 2024|Case Studies, ENT & Allergy, Healthcare|

Mid-Michigan ENT Case Study ...

FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy

FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy

By Eric Yetter|September 27, 2024|Deals, ENT & Allergy, Healthcare, Mergers & Acquisitions News|

FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership ...

FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023

FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023

By Amanda Damato|July 28, 2023|Advanced Manufacturing, Agriculture, Auto parts and accessories, Automotive Aftermarket, Automotive Dealers, Behavioral Health, Biotech, Blogs, Car Washes, Cardiology, Cloud Services, Collision, Construction, Consumer, Dermatology, Distribution, Downloads, E-commerce, E-Learning, Education & Human Capital Development News, Electronics, Engineering, ENT & Allergy, Entertainment, Environmental Services, Federal Contracting, Financial Services, FOCUS Sale Preparation, Food & Beverage, Gastroenterology, Government and Defense, Healthcare, Home Health & Hospice, Human Capital Management, Industrials and Energy, Managed Service Providers, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures, Oil and Lube, Paint Jobbers, Supply Chain, Technology Services, Telecom Technologies & Services, Tire and Service|

FOCUS Investment Banking Named #1 Lower Middle Market M&A ...

ENT & Allergy – Q4 2021 Acquisition Activity and Outlook

ENT & Allergy – Q4 2021 Acquisition Activity and Outlook

By Kahla Cooper|January 19, 2022|ENT & Allergy, Healthcare|

New Harbor Capital Launches New ENT Platform; Waypoint Capital Acquires Allergy Partners

The fourth quarter of 2021 delivered six reported ENT practice acquisition, marking the highest ENT acquisition quarter we have seen to date.

Cruinn Diagnostics Case Study

Cruinn Diagnostics Case Study

By FOCUS Investment Banking|December 31, 2021|Behavioral Health, Biotech, Cardiology, Case Studies, Dermatology, ENT & Allergy, Gastroenterology, Healthcare, Home Health & Hospice, Life Sciences, Ophthalmology, Orthopedics, Urology, Women's Health|

Cruinn Diagnostics Case Study FOCUS advised Cruinn Diagnostics, ...

ENT & Allergy – Q3 2021 Acquisition Activity and Outlook

ENT & Allergy – Q3 2021 Acquisition Activity and Outlook

By Kahla Cooper|October 15, 2021|ENT & Allergy, Healthcare|

After a Quiet Quarter for ENT & Allergy Practice Acquisitions, We See Increasing Opportunity in Q4

The third quarter of 2021 delivered one major reported ENT practice acquisition, still far below the peak of activity in Q1. In September, an investment from The Beekman Group formed a partnership with Allergy & ENT Associates, a management services organization that supports a network of sixteen ENT clinics in the Greater Houston area.

ENT & Allergy Report – Q2 2021 Acquisition Activity and Outlook

ENT & Allergy Report – Q2 2021 Acquisition Activity and Outlook

By Kahla Cooper|July 23, 2021|ENT & Allergy, Healthcare|

Quiet Quarter for ENT & Allergy Practices Acquisitions. Expect Increasing Opportunity for Large Practice Sellers

Although we did not track any reported transactions in Q2, the first half of 2021 delivered three reported ENT practice acquisitions.